坦桑尼亚Muhimbili国家医院镰状细胞项目的十年回顾。

Q2 Medicine
BMC Hematology Pub Date : 2018-11-14 eCollection Date: 2018-01-01 DOI:10.1186/s12878-018-0125-0
Julie Makani, Furahini Tluway, Abel Makubi, Deogratius Soka, Siana Nkya, Raphael Sangeda, Josephine Mgaya, Stella Rwezaula, Fenella J Kirkham, Christina Kindole, Elisha Osati, Elineema Meda, Robert W Snow, Charles R Newton, David Roberts, Muhsin Aboud, Swee Lay Thein, Sharon E Cox, Lucio Luzzatto, Bruno P Mmbando
{"title":"坦桑尼亚Muhimbili国家医院镰状细胞项目的十年回顾。","authors":"Julie Makani,&nbsp;Furahini Tluway,&nbsp;Abel Makubi,&nbsp;Deogratius Soka,&nbsp;Siana Nkya,&nbsp;Raphael Sangeda,&nbsp;Josephine Mgaya,&nbsp;Stella Rwezaula,&nbsp;Fenella J Kirkham,&nbsp;Christina Kindole,&nbsp;Elisha Osati,&nbsp;Elineema Meda,&nbsp;Robert W Snow,&nbsp;Charles R Newton,&nbsp;David Roberts,&nbsp;Muhsin Aboud,&nbsp;Swee Lay Thein,&nbsp;Sharon E Cox,&nbsp;Lucio Luzzatto,&nbsp;Bruno P Mmbando","doi":"10.1186/s12878-018-0125-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Africa has the highest burden of Sickle cell disease (SCD) but there are few large, systematic studies providing reliable descriptions of the disease spectrum. Tanzania, with 11,000 SCD births annually, established the Muhimbili Sickle Cell program aiming to improve understanding of SCD in Africa. We report the profile of SCD seen in the first 10 years at Muhimbili National Hospital (MNH).</p><p><strong>Methods: </strong>Individuals seen at MNH known or suspected to have SCD were enrolled at clinic and laboratory testing for SCD, haematological and biochemical analyses done. Ethnicity was self-reported. Clinical and laboratory features of SCD were documented. Comparison was made with non-SCD population as well as within 3 different age groups (< 5, 5-17 and ≥ 18 years) within the SCD population.</p><p><strong>Results: </strong>From 2004 to 2013, 6397 individuals, 3751 (58.6%) SCD patients, were enrolled, the majority (47.4%) in age group 5-17 years. There was variation in the geographical distribution of SCD. Individuals with SCD compared to non-SCD, had significantly lower blood pressure and peripheral oxygen saturation (SpO<sub>2</sub>). SCD patients had higher prevalence of severe anemia, jaundice and desaturation (SpO<sub>2</sub> < 95%) as well as higher levels of reticulocytes, white blood cells, platelets and fetal hemoglobin. The main causes of hospitalization for SCD within a 12-month period preceding enrolment were pain (adults), and fever and severe anemia (children). When clinical and laboratory features were compared in SCD within 3 age groups, there was a progressive decrease in the prevalence of splenic enlargement and an increase in prevalence of jaundice. Furthermore, there were significant differences with monotonic trends across age groups in SpO2, hematological and biochemical parameters.</p><p><strong>Conclusion: </strong>This report confirms that the wide spectrum of clinical expression of SCD observed elsewhere is also present in Tanzania, with non-uniform geographical distribution across the country. Age-specific analysis is consistent with different disease-patterns across the lifespan.</p>","PeriodicalId":37740,"journal":{"name":"BMC Hematology","volume":"18 ","pages":"33"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12878-018-0125-0","citationCount":"29","resultStr":"{\"title\":\"A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania.\",\"authors\":\"Julie Makani,&nbsp;Furahini Tluway,&nbsp;Abel Makubi,&nbsp;Deogratius Soka,&nbsp;Siana Nkya,&nbsp;Raphael Sangeda,&nbsp;Josephine Mgaya,&nbsp;Stella Rwezaula,&nbsp;Fenella J Kirkham,&nbsp;Christina Kindole,&nbsp;Elisha Osati,&nbsp;Elineema Meda,&nbsp;Robert W Snow,&nbsp;Charles R Newton,&nbsp;David Roberts,&nbsp;Muhsin Aboud,&nbsp;Swee Lay Thein,&nbsp;Sharon E Cox,&nbsp;Lucio Luzzatto,&nbsp;Bruno P Mmbando\",\"doi\":\"10.1186/s12878-018-0125-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Africa has the highest burden of Sickle cell disease (SCD) but there are few large, systematic studies providing reliable descriptions of the disease spectrum. Tanzania, with 11,000 SCD births annually, established the Muhimbili Sickle Cell program aiming to improve understanding of SCD in Africa. We report the profile of SCD seen in the first 10 years at Muhimbili National Hospital (MNH).</p><p><strong>Methods: </strong>Individuals seen at MNH known or suspected to have SCD were enrolled at clinic and laboratory testing for SCD, haematological and biochemical analyses done. Ethnicity was self-reported. Clinical and laboratory features of SCD were documented. Comparison was made with non-SCD population as well as within 3 different age groups (< 5, 5-17 and ≥ 18 years) within the SCD population.</p><p><strong>Results: </strong>From 2004 to 2013, 6397 individuals, 3751 (58.6%) SCD patients, were enrolled, the majority (47.4%) in age group 5-17 years. There was variation in the geographical distribution of SCD. Individuals with SCD compared to non-SCD, had significantly lower blood pressure and peripheral oxygen saturation (SpO<sub>2</sub>). SCD patients had higher prevalence of severe anemia, jaundice and desaturation (SpO<sub>2</sub> < 95%) as well as higher levels of reticulocytes, white blood cells, platelets and fetal hemoglobin. The main causes of hospitalization for SCD within a 12-month period preceding enrolment were pain (adults), and fever and severe anemia (children). When clinical and laboratory features were compared in SCD within 3 age groups, there was a progressive decrease in the prevalence of splenic enlargement and an increase in prevalence of jaundice. Furthermore, there were significant differences with monotonic trends across age groups in SpO2, hematological and biochemical parameters.</p><p><strong>Conclusion: </strong>This report confirms that the wide spectrum of clinical expression of SCD observed elsewhere is also present in Tanzania, with non-uniform geographical distribution across the country. Age-specific analysis is consistent with different disease-patterns across the lifespan.</p>\",\"PeriodicalId\":37740,\"journal\":{\"name\":\"BMC Hematology\",\"volume\":\"18 \",\"pages\":\"33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/s12878-018-0125-0\",\"citationCount\":\"29\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Hematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s12878-018-0125-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12878-018-0125-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 29

摘要

背景:非洲镰状细胞病(SCD)负担最重,但很少有大型、系统的研究提供可靠的疾病谱描述。坦桑尼亚每年有1.1万例SCD新生儿,该国建立了Muhimbili镰状细胞项目,旨在提高非洲对SCD的认识。我们报告了在Muhimbili国立医院(MNH)头10年看到的SCD的概况。方法:在MNH发现的已知或怀疑患有SCD的个体在临床和实验室进行SCD检测,并进行血液学和生化分析。种族是自我报告的。记录了SCD的临床和实验室特征。结果:2004 - 2013年共纳入6397例SCD患者,其中3751例(58.6%)SCD患者,其中大多数(47.4%)为5-17岁年龄组。SCD的地理分布存在差异。与非SCD患者相比,SCD患者的血压和外周血氧饱和度(SpO2)显著降低。SCD患者的严重贫血、黄疸和去饱和发生率较高(SpO2)。结论:本报告证实,SCD在其他地方的广泛临床表达在坦桑尼亚也存在,但在全国的地理分布不均匀。年龄特异性分析与生命周期中不同的疾病模式相一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania.

A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania.

A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania.

A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania.

Background: Africa has the highest burden of Sickle cell disease (SCD) but there are few large, systematic studies providing reliable descriptions of the disease spectrum. Tanzania, with 11,000 SCD births annually, established the Muhimbili Sickle Cell program aiming to improve understanding of SCD in Africa. We report the profile of SCD seen in the first 10 years at Muhimbili National Hospital (MNH).

Methods: Individuals seen at MNH known or suspected to have SCD were enrolled at clinic and laboratory testing for SCD, haematological and biochemical analyses done. Ethnicity was self-reported. Clinical and laboratory features of SCD were documented. Comparison was made with non-SCD population as well as within 3 different age groups (< 5, 5-17 and ≥ 18 years) within the SCD population.

Results: From 2004 to 2013, 6397 individuals, 3751 (58.6%) SCD patients, were enrolled, the majority (47.4%) in age group 5-17 years. There was variation in the geographical distribution of SCD. Individuals with SCD compared to non-SCD, had significantly lower blood pressure and peripheral oxygen saturation (SpO2). SCD patients had higher prevalence of severe anemia, jaundice and desaturation (SpO2 < 95%) as well as higher levels of reticulocytes, white blood cells, platelets and fetal hemoglobin. The main causes of hospitalization for SCD within a 12-month period preceding enrolment were pain (adults), and fever and severe anemia (children). When clinical and laboratory features were compared in SCD within 3 age groups, there was a progressive decrease in the prevalence of splenic enlargement and an increase in prevalence of jaundice. Furthermore, there were significant differences with monotonic trends across age groups in SpO2, hematological and biochemical parameters.

Conclusion: This report confirms that the wide spectrum of clinical expression of SCD observed elsewhere is also present in Tanzania, with non-uniform geographical distribution across the country. Age-specific analysis is consistent with different disease-patterns across the lifespan.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BMC Hematology
BMC Hematology Medicine-Hematology
CiteScore
4.10
自引率
0.00%
发文量
0
期刊介绍: BMC Hematology is an open access, peer-reviewed journal that considers articles on basic, experimental and clinical research related to hematology. The journal welcomes submissions on non-malignant and malignant hematological diseases, hemostasis and thrombosis, hematopoiesis, stem cells and transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信